SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial Officer

Finance leader joins SAB with more than 25 years of experience as a leading biotech equity research analystSIOUX FALLS, S.D., Oct. 24, 2023 -- SAB Biotherapeutics, Inc. , today announced that...

Related Keywords

United States ,America ,Rodman Renshaw ,Samuelj Reich ,Robertson Stephens ,Eddiej Sullivan ,Russell Beyer ,Hambrecht Quist ,Michaelg King Jr ,Nasdaq ,Linkedin ,Exchange Commission ,Ef Hutton Group ,Head Of Healthcare Research ,Biotherapeutics Inc ,Twitter ,Chief Financial ,Alex Brown ,Vector Securities ,Healthcare Research ,City University ,Chief Executive Officer ,Chairman Samuel ,Private Securities Litigation Reform Act ,Markets ,